A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV

NCT02751996 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B
Hepatitis, Viral

Interventions

DRUG: SB 9200
DRUG: Placebo
DRUG: Tenofovir

Sponsor

F-star Therapeutics, Inc.